Skip to content

Clinical trials

Observational Genetic Diseases, Inborn trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genetic Diseases, Inborn Phase: Observational Country / region: Germany Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20061
20081
20101
20152
20173
20182
20191
20221
20234
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting4
Withdrawn2
Enrolling by invitation1
Active, not recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S3
CENTOGENE GmbH Rostock2
University of Bonn2
Azafaros B.V.1
BioMarin Pharmaceutical1
CSL Behring1
Charite University, Berlin, Germany1
Editas Medicine, Inc.1
Friedreich's Ataxia Research Alliance1
Imagine Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genetic Diseases, Inborn20
Lysosomal Storage Diseases5
Lipid Metabolism Disorders3
Metabolic Diseases3
Metabolism, Inborn Errors3
Nervous System Diseases3
Rare Diseases3
Blood Coagulation Disorders2
Bone Diseases, Metabolic2
Brain Diseases2

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.